Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce the font size Increase the font size  
 
 

Our activities

Contact us

Sanofi

To get more information about our products,
please call (91-22) 28032000

Content :

Sanofi-Synthelabo (India) Private Limited: Product range

Sanofi India provides medicines for the treatment of patients in several therapeutic areas: cardiology, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines.

Healthcare professionals seeking abbreviated prescribing information of the prescription product portfolio of Sanofi-Synthelabo (India) Private Ltd. please click here

 
List of direct links to sections :

Biosurgery

  • Synvisc One®
  • Seprafilm®

Cardiology

  • Adenocor®
  • Cordarone®
  • Cordarone® Injection
  • Cordarone® X
  • Primacor®

Central Nervous System

  • Depakote®
  • Depakote® XR
  • Solian®
  • Stilnoct®
  • Valparin® Injection
  • Valparin® 200 Syrup
  • Valparin® 200 Alkalets
  • Valparin® 500 Alkalets
  • Valparin® chrono 200
  • Valparin® chrono 300
  • Valparin® chrono 500
  • Vinlep™

Consumer Healthcare

  • Lactacyd®
  • Myoril®

Internal Medicine

  • Enterogermina®

Oncology

  • Fasturtec®
  • Jevtana®
  • Thymoglobuline®
  • Fludara® Injection

Renal

  • Renvela®
  • Renvela® Powder

Thrombosis

  • Plavix®

Updated October 01, 2015

Module :

Medical Information / Pharmacovigilance

All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.

Pharmacovigilance remains a key activity in the assessment of the therapeutic value of products. Sanofi ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide.
For reporting adverse events, please send an email to PV.india@sanofi.com

A key activity of Sanofi is to provide updated medical information in compliance with Indian regulations, on its products, to healthcare professionals.
For medical information, please send your queries to medinfo.india@sanofi.com

You can also call us between 9AM and 5PM on any working day* at 022-28032000. Please select IVRS option 2 for medical information and IVRS option 3 for reporting adverse events.

*Please note that we are closed on Saturday, Sunday and Public Holidays.